X0407 4 2023-01-27 1 0001788028 Jasper Therapeutics, Inc. JSPR 0001765710 Qiming U.S. Healthcare Fund II, L.P. 11100 NE 8TH ST., SUITE 200 BELLEVUE WA 98004 0 0 1 0 0001868862 Qiming U.S. Healthcare GP II, LLC 11100 NE 8TH ST., SUITE 200 BELLEVUE WA 98004 0 0 1 0 0001242126 MCDADE MARK C/O QIMING U.S. VENTURES MANAGEMENT, LLC 11100 NE 8TH ST., SUITE 200 BELLEVUE WA 98004 0 0 1 0 0001248153 RIESCHEL GARY E C/O QIMING U.S. VENTURES MANAGEMENT, LLC 11100 NE 8TH ST., SUITE 200 BELLEVUE WA 98004 0 0 1 0 0 Voting Common Stock 2023-01-27 4 P 0 2666666 1.50 A 8519648 D The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP and may be deemed to share voting and dispositive power over the shares held by Qiming. Each of Qiming GP and Messrs. Rieschel and McDade disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein. Qiming U.S. Healthcare Fund II, L.P., By: Qiming U.S. Healthcare GP II, LLC, its general partner, By /s/ Mark McDade, Managing Partner 2023-04-11 Qiming U.S. Healthcare GP II, LLC, By /s/ Mark McDade, Managing Partner 2023-04-11 /s/ Mark McDade 2023-04-11 /s/ Gary Rieschel 2023-04-11